Order Article Reprints

Batinić J, Dreta B, Rinčić G, Mrdeža A, Jakobac KM, Krišto DR, Vujčić M, Piršić M, Jonjić Ž, Periša V, et al. Outcomes of Ixazomib Treatment in Relapsed and Refractory Multiple Myeloma: Insights from Croatian Cooperative Group for Hematologic Diseases (KROHEM). Medicina. 2024; 60(11):1905. https://doi.org/10.3390/medicina60111905

Batinić, Josip, Barbara Dreta, Goran Rinčić, Antonia Mrdeža, Karla Mišura Jakobac, Delfa Radić Krišto, Milan Vujčić, Mario Piršić, Željko Jonjić, Vlatka Periša, and et al. 2024. "Outcomes of Ixazomib Treatment in Relapsed and Refractory Multiple Myeloma: Insights from Croatian Cooperative Group for Hematologic Diseases (KROHEM)" Medicina 60, no. 11: 1905. https://doi.org/10.3390/medicina60111905

Batinić, J., Dreta, B., Rinčić, G., Mrdeža, A., Jakobac, K. M., Krišto, D. R., Vujčić, M., Piršić, M., Jonjić, Ž., Periša, V., Sinčić Petričević, J., Coha, B., Holik, H., Valković, T., Stanić, M., Krečak, I., Stojanović, A., Sajfert, D., & Bašić-Kinda, S. (2024). Outcomes of Ixazomib Treatment in Relapsed and Refractory Multiple Myeloma: Insights from Croatian Cooperative Group for Hematologic Diseases (KROHEM). Medicina, 60(11), 1905. https://doi.org/10.3390/medicina60111905